TMCnet - World's Largest Communications and Technology Community



Overlake Medical Center Targets Earlier Detection of Lung Cancer with Affordable Screening Alternative
[June 18, 2014]

Overlake Medical Center Targets Earlier Detection of Lung Cancer with Affordable Screening Alternative

BELLEVUE, Wash. --(Business Wire)--

Overlake Medical Center physicians are hoping to increase the odds of surviving lung cancer with earlier detection.

The hospital launched a new lung cancer screening program aimed to help identify lung cancer in its earlier stages, when five-year survival rates can reach as high as 75 percent with surgery.

"Unfortunately, many patients we see are already in the later stages of lung cancer when the chances of successful treatment are significantly reduced," said Todd Freudenberger, MD, an Overlake specialist in pulmonary medicine and one of the hospital's leading lung cancer experts. "With earlier detection, we know we can make a significant difference in the lives of our patients and tilt the odds back in their favor."

The new lung cancer screening program uses an affordable, low-dose CT scan that uses only 10 to 30 percent as much radiation compared to a standard-dose CT scan. All patients have to do is hold their breath for six seconds during the screening.

The hospital recommends patients who have smoked for 15 or more years should discuss having the low-dose cancer screening with their primary care provider.

"The discouraging reality about lung cancer is early stages of the cancer are not easily detected without such screenings," said Dr. Freudenberger. "Patients become aware of the disease when symptoms become apparent. Too often, this signals a later, less treatable, stage of disease. We know we can catch this disease earlier with the right screening technology. This gives us the best chance of making a difference."

Stage I lung cancer has a 60 percent five-year survival rate, which rises to at least 75 percent with surgery. Later stage lung cancer, on the other hand, has a very por prognosis. The five-year survival rate for Stage III lung cancer is a dismal 15 percent and the rate for Stage IV lung cancer is less than one percent.

Urged on by recent studies indicating that CT screening significantly reduces lung cancer deaths, an advisory panel to Medicare convened in May to discuss the low-dose CT screening for lung cancer and assess whether Medicare should cover the screening in high-risk individuals. However, the panel voted against recommending national Medicare coverage for the annual screening for lung cancer.

"Having Medicare and other insurers cover screening would clearly save lives. Until these payers decide to cover this important screening tool, our goal is to keep low-dose CT screening as affordable as possible," said Dr. Freudenberger.

Overlake Medical Center's low-dose lung cancer screening costs $199.

Should the screening reveal a patient does, in fact, have lung cancer, Overlake Medical Center's Cancer Center provides the latest and most technologically advanced methods of treatment, including surgery, chemotherapy, radiation therapy and targeted drug therapy.

Overlake's unique lung cancer program is distinguished by state-of-the-art diagnostic capabilities, leading-edge treatments and a skilled, interdisciplinary staff, which includes a dedicated thoracic surgeon and a lung cancer navigator. The lung cancer navigator is available to provide guidance to patients and their families throughout the treatment process.

According to the American Cancer Society, lung cancer is the second most common type of cancer diagnosed in men and women. In fact, lung cancer causes more deaths in the United States than breast, colon, pancreas and prostate cancer combined.

For more information about Overlake Medical Center's Lung Cancer program, go to:

Reporters interested in talking to Dr. Todd Freudenberger about the lung cancer screening should contact Daven Rosener at The Keller Group, 253-307-5402 or email,

About Overlake Medical Center

Overlake Medical Center is a nonprofit, non-tax-supported regional medical center with a network of primary care, specialty and urgent care medical clinics throughout the Eastside. The hospital is licensed for 349 beds and offers a comprehensive range of services, including cardiac care, cancer care, general and specialty surgery, women's programs, senior care and psychiatric services, and it was the first Level III trauma service on the Eastside. For more information, visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy